Verified

William Beaumont Prize in Gastroenterology

American Gastroenterological Association

Description

Established in 1976, the William Beaumont Prize recognizes an individual who has made a major contribution (a single accomplishment or series of accomplishments) that has significantly advanced the care of patients with digestive diseases through clinical or translational research. Beginning in 2015, the prize has been awarded annually.

Selection process

The recipient is selected by the AGA Recognition Prizes Panel constituting members of the AGA Diversity Committee, AGA Institute Clinical Guidelines Committee, AGA Institute Education and Training Committee, AGA Institute Practice Management and Economics Committee, and AGA Institute Research Policy Committee.
The AGA Governing Board ratifies the recipient.
An individual may only receive one AGA recognition prize per year.

Nominations are reviewed according to the eligibility criteria listed above and the following review and selection criteria. Nominees:

Have made a unique and outstanding contribution(s) of major importance to the field that will lead or has led to important new insights or advances in prevention, diagnosis, management or treatment of digestive disease.
Have an impactful body of clinical and/or translational research outputs that have significantly impacted the understanding and/or practice of gastroenterology in relation to patient care.
Have demonstrated exemplary service to AGA through service or leadership on AGA committees, journal editorial boards and/or the governing board. Recognition as an AGA Fellow is also considered.
Have generously contributed their expertise and leadership to the field, through for example:
- Peer-review of grants.
- Service on journal editorial boards.
- Leadership and/or service on graduate and/or medical school committees.

Recognition

The recipient will receive a $5,000 monetary prize and is recognized at the AGA Awards Ceremony during Digestive Disease Week®. AGA will reimburse the recipient’s travel expenses and provide hotel accomodations for up to two nights. Travel expenses for one guest are also reimbursed.

Nomination process

All nominations must be submitted online by a primary nominator who is an AGA member. The names of additional AGA members who support the nomination should be listed on the nomination form and included as signatories in the nomination letter.

Complete nomination packages include the following supporting materials:

A nomination letter, not to exceed three pages (1,800 words), copied directly into the nomination form. The primary nominator will sign the letter in the nomination system and can identify additional AGA members to endorse the nomination.
The nominee’s curriculum vitae. Please upload the file as a PDF titled with the nominee’s last name and first initial (e.g., DoeJ_CV.pdf).

Including additional endorsers is optional and has no impact on nomination review. Endorsers of successful nominations will receive an invitation to attend the Awards Ceremony during DDW to witness their nominee accept the recognition prize.

Current service on the AGA Recognition Prizes Panel and AGA Governing Board disqualifies individuals from submitting, supporting, or being considered for nominations.

AI Based Application Success Predictor

🧠 1. Strong Focus on Gastroenterology & Hepatology (Non-Negotiable)

Projects must directly address:
- GI or liver diseases
Common areas:
- Inflammatory bowel disease (IBD)
- GI cancers
- Liver disease (NAFLD, cirrhosis)
- Microbiome research

👉 Weak GI relevance → low success probability

🎯 2. Clear Clinical or Patient Impact (Top Predictor)

Successful proposals:

Demonstrate:
- Improvement in diagnosis, treatment, or outcomes
Focus on:
- Patient care
- Disease management
- Prevention

👉 Key question:
“Will this improve care for patients with GI or liver disease?”

🔄 3. Translational Research (Bench → Bedside) (Critical)

Preference for:
- Translational and clinically relevant research
Includes:
- Biomarkers
- Therapeutics
- Clinical trials

👉 Pure basic science is less competitive unless clinically linked

👩‍🔬 4. Early-Career Investigator Development (Major Priority)

Many AGA awards target:
- Fellows and junior faculty

Evaluation includes:

Career trajectory
Independence potential

👉 Strong mentorship is essential

🧪 5. Feasible, Well-Structured Study Design

Must include:
- Clear aims
- Methodology
- Timeline

👉 Overly ambitious or poorly designed studies are frequently rejected

💡 6. Innovation in Key GI Areas

High success rates in:

Microbiome & gut–brain axis
Precision medicine
AI in GI diagnostics
Novel therapeutics

👉 Innovation must be clinically meaningful

🤝 7. Strong Mentorship & Institutional Support

Mentor should:
- Have a strong research track record
Institution must provide:
- Clinical exposure
- Research infrastructure

👉 Mentorship quality significantly impacts outcomes

📊 8. Alignment with AGA Priority Topics

Higher success when aligned with:

Digestive cancers
Chronic liver disease
IBD
Functional GI disorders

👉 Topic alignment improves competitiveness

📈 9. Potential for Future Funding & Publications

AGA funding is often:
- Seed funding for NIH or major grants

👉 Projects that:

Generate preliminary data
Lead to publications
→ score higher

💰 10. Appropriate Scope & Budget

Funding is typically:
- Pilot to mid-scale
Projects must be:
- Focused
- Achievable

👉 Over-scoped proposals are commonly rejected

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

GI/hepatology focus
Clinical impact
Translational relevance

Moderate predictors:
4. Early-career development
5. Feasibility
6. Innovation

Supporting factors:
7. Mentorship
8. Topic alignment
9. Future funding potential

💡 Insider Insight

Compared to NIH:

American Gastroenterological Association is:
👉 clinically focused + career-development oriented
👉 emphasizes pilot and translational research

👉 Key evaluation question:
“Will this project improve GI care and help develop a future investigator?”

✔️ What wins:

Translational GI research
Strong mentorship
Feasible pilot studies

❌ What struggles:

Pure basic science
Weak clinical relevance
Overly ambitious projects

Specialties

Gastroenterology

Eligibility Requirements

Nominees must have made major clinical or translational research contributions in digestive disease; however, the nominee need not be gastroenterologists and consideration will be given to scientists and medical professionals from all fields.
Nominees must have a current AGA membership.
Recipients of the William Beaumont Prize become ineligible to receive other AGA recognition prizes for a period of three years subsequent to their receipt of the award.

Sponsor Details

Sponsor Institute/Organizations: American Gastroenterological Association

Sponsor Type: Corporate/Non-Profit

Address: 4930 Del Ray Avenue, Bethesda, MD 20814

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity